Psoriasis and coronary heart disease-not as severe as predicted

Y Hadi1, T Or2,1, G Moady2,3

  • 1Department  of Cardiology, Galilee Medical Center, 1 Ben Tzvi Blvd., Nahariya 2210001, Israel.

Insights

Psoriasis patients showed less severe coronary artery disease (CAD) than those without psoriasis, despite psoriasis being a potential cardiovascular disease (CVD) risk factor. Anti-inflammatory treatments did not explain this finding.

Area of Science:

  • Cardiology
  • Dermatology
  • Systemic Inflammatory Diseases

Background:

  • Psoriasis is a systemic inflammatory condition linked to cardiovascular disease (CVD).
  • The precise impact of psoriasis on coronary artery disease (CAD) severity remains incompletely understood.
  • This study investigates the relationship between psoriasis and CAD severity.

Purpose of the Study:

  • To determine the correlation between psoriasis and the severity of coronary artery disease (CAD).
  • To compare CAD severity in patients with and without psoriasis, matched for key cardiovascular risk factors.

Main Methods:

  • Retrospective case-control study involving 59 patients with psoriasis and 59 matched controls.
  • Coronary angiography data was analyzed.
  • CAD severity was assessed by the number and location of affected coronary vessels.

Main Results:

  • CAD severity was significantly lower in patients with psoriasis compared to the control group (P=0.038).
  • A higher proportion of psoriasis patients had mild or no CAD (62.7%) versus severe CAD (37.3%).
  • Conversely, the majority of non-psoriasis patients (57.6%) exhibited severe CAD.

Conclusions:

  • Psoriasis patients demonstrated less severe coronary artery disease than the general population.
  • The observed difference in CAD severity was not explained by the use of anti-inflammatory medications.
  • Psoriasis may be a risk factor for CAD, but its clinical manifestation in the coronary arteries appears less aggressive in affected individuals.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
139
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
563
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
102
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
125
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
158
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
431